BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1013 related articles for article (PubMed ID: 21864595)

  • 1. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
    Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
    J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
    Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
    J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral.
    Italia JL; Bhatt DK; Bhardwaj V; Tikoo K; Kumar MN
    J Control Release; 2007 Jun; 119(2):197-206. PubMed ID: 17399839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting.
    Md S; Ali M; Baboota S; Sahni JK; Bhatnagar A; Ali J
    Drug Dev Ind Pharm; 2014 Feb; 40(2):278-87. PubMed ID: 23369094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
    Mittal G; Sahana DK; Bhardwaj V; Ravi Kumar MN
    J Control Release; 2007 May; 119(1):77-85. PubMed ID: 17349712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming barriers in Pseudomonas aeruginosa lung infections: Engineered nanoparticles for local delivery of a cationic antimicrobial peptide.
    d'Angelo I; Casciaro B; Miro A; Quaglia F; Mangoni ML; Ungaro F
    Colloids Surf B Biointerfaces; 2015 Nov; 135():717-725. PubMed ID: 26340361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections.
    Günday Türeli N; Torge A; Juntke J; Schwarz BC; Schneider-Daum N; Türeli AE; Lehr CM; Schneider M
    Eur J Pharm Biopharm; 2017 Aug; 117():363-371. PubMed ID: 28476373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
    Patil GB; Surana SJ
    J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.
    Tang J; Chen JY; Liu J; Luo M; Wang YJ; Wei XW; Gao X; Wang BL; Liu YB; Yi T; Tong AP; Song XR; Xie YM; Zhao Y; Xiang M; Huang Y; Zheng Y
    Int J Pharm; 2012 Jul; 431(1-2):210-21. PubMed ID: 22561795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral delivery of spray dried PLGA/amifostine nanoparticles.
    Pamujula S; Graves RA; Freeman T; Srinivasan V; Bostanian LA; Kishore V; Mandal TK
    J Pharm Pharmacol; 2004 Sep; 56(9):1119-25. PubMed ID: 15324480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting.
    Huo D; Deng S; Li L; Ji J
    Int J Pharm; 2005 Jan; 289(1-2):63-7. PubMed ID: 15652199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery.
    Cai H; Liang Z; Huang W; Wen L; Chen G
    Int J Pharm; 2017 Oct; 532(1):55-65. PubMed ID: 28870763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
    Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
    J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises.
    Ungaro F; d'Angelo I; Miro A; La Rotonda MI; Quaglia F
    J Pharm Pharmacol; 2012 Sep; 64(9):1217-35. PubMed ID: 22881435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced properties of discrete pulmonary deoxyribonuclease I (DNaseI) loaded PLGA nanoparticles during encapsulation and activity determination.
    Osman R; Kan PL; Awad G; Mortada N; El-Shamy AE; Alpar O
    Int J Pharm; 2011 Apr; 408(1-2):257-65. PubMed ID: 21335080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
    Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
    Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.